September 23, 2014 9:21 AM ET

Pharmaceuticals

Company Overview of Pharnext SAS

Company Overview

Pharnext SAS, a biopharmaceutical company, engages in the development of treatments for severe neurological diseases. The company specializes in drug repositioning. Its target pathologies include Charcot-Marie-Tooth disease; and diabetic and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in general and peripheral neuropathies. The company was founded in 2007 and is based in Paris, France.

Pépinière Santé Cochin

29 rue du Faubourg Saint Jacques

Paris,  75014

France

Founded in 2007

Phone:

33 1 55 42 62 00

Fax:

33 1 55 42 62 01

Key Executives for Pharnext SAS

Co-Founder
Age: 61
Chief Executive Officer and Director
Age: 56
Co-Founder and Administrative & Financial Director
Co-Founder and Data Mining Officer
Co-founder and Biology Officer
Compensation as of Fiscal Year 2014.

Pharnext SAS Key Developments

Ipsen Joins Pharnext's Board of Directors

Pharnext announced that Ipsen has joined its Board of Directors. Ipsen will be represented on Pharnext's board of directors by Marc de Garidel, CEO.

Similar Private Companies By Industry

Company Name Region
Recipharm Monts SAS Europe
Ennagram Europe
Service Médical International SAS Europe
PPG-Sipsy SAS Europe
EUSA Pharma SAS Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pharnext SAS, please visit www.pharnext.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.